Nutrition and depression: The role of folate

Nutrition Reviews

Volumn 55, Issue 5, 1997, Pages 145-149

  Alpert, Jonathan E ^a,b   Fava, Maurizio ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ANTIDEPRESSANT AGENT; FOLIC ACID; SEROTONIN UPTAKE INHIBITOR;

BRAIN METABOLISM; DEPRESSION; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HUMAN; MOOD; NUTRITION; REVIEW;

EID: 0030839990     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1997.tb06468.x     Document Type: Review

References (38)

1. Young SN, Ghadirian AM. Folic acid and psychopathology. Prog Neuropsychopharmocol Biol Psychiatry 1989;13:841-63
2. Reynolds E, Stramentinoli G. Folic acid, Sadenosylmethionine and affective disorders. Psychol Med 1983;13:705-10
3. Mischoulon D. The role of folate in major depression: mechanisms and clinical implications. Am Soc Clin Psychopharmacol Prog Notes 1996;7(2):4-5
4. Herbert V. Experimental nutritional folate deficiency in man. Trans Assoc Am Physicians 1961;75:307-20
5. Shorvon SD, Carney MWP, Chanarin I, Reynolds EH. The neuropsychiatry of megaloblastic anaemia. Br Med J 1980;281:1036-38
6. Abou-Saleh MT, Coppen A. Serum and red blood cell folate in depression. Acta Psychiatr Scand 1989;80:78-82
7. Carney MWP, Chary TKN, Laundy M, et al. Red cell folate concentrations in psychiatric patients. J Affect Disord 1990;19:207-13
8. Reynolds EH, Preece JM, Bailey J, Coppen A. Folate deficiency in depressive illness. Br J Psychiatry 1970;117:287-92
9. Godfrey PSA, Toone BK, Carney MWP, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990;336:392-95
10. Fava M, Borus JS, Alpert JE, et al. Folate, B12, and homocysteine in major depressive disorder. Am J Psychiatry 1997;154:426-8
11. Ghadirian AM, Anath J, Engelsmann F. Folic acid deficiency in depression. Psychosomatics 1980;21: 926-9
12. Coppen A, Abou-Saleh MT. Plasma folate and affective morbidity during long-term lithium therapy. Br J Psychiatry 1982;141:87-9
13. Wilkinson A, Anderson D, Abou-Saleh M, et al. 5-Methyltetrahydrofolate level in the serum of depressed subjects and its relationship to the outcome of ECT. J Affect Disord 1994;32:3:163-68
14. Levitt AJ, Joffe RT. Folate, B12, and life course of depressive illness. Biol Psychiatry 1989;25:867-72
15. Alpert M, Silva R, Pouget E. Folate as a predictor of response to sertraline or nortriptyline in geriatric depression. Presented at the 36th annual meeting of the NCDEU. Boca Raton, FL, May 28-31, 1996
16. Reynolds E. Effects of folic acid on the mental state and fit frequency of drug-treated epileptic patients. Lancet 1967;i:1086-8
17. Botez M, Botez T, Leveille J, et al. Neuropsychological correlates of folic acid deficiency: facts and hypotheses. In Botez M, Reynolds CH, eds. Folic acid in neurology, psychiatry and internal medicine. New York: Raven Press, 1979;435-61
18. Carney M, Sheffield, BF. Associations of subnormal serum folate and vitamin B12 and effects of replacement therapy. J Nerv Ment Dis 1970;150:404-12
19. Coppen A, Chaudry S, Swade C. Folic acid enhances lithium prophylaxis. J Affect Disord 1986;10:9-13
20. Guaraldi G, Fava M, Mazzi F, LaGreca P. An open trial of methyltetrahydrofolate (MTHF) in elderly depressed patients. Ann Clin Psychiatry 1993;5:101-6
21. Hunter R, Jones M, Jones T, Matthews D. Serum B12 and folate concentrations in mental patients. Br J Psychiatry 1967;113:1291-5
22. Botez M, Young S, Bachevalier J, Gauthier S. Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature (Lond) 1979;278: 182-3
23. Shane B, Stokstad ELB. Vitamin B12-folate interrelationships. Annu Rev Nutr 1985;5:115-41
24. Bottiglieri T, Hyland K, Reynolds EH. The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders. Drugs 1994;48:137-52
25. Cantoni GL. S-adenosylmethionine: a new intermediate formed enzymatically from Imethionine and adenosine triphosphate. J Biol Chem 1953;204:403-16
26. Smythies JR. Biochemistry of schizophrenia. Postgrad Med J 1963;39:26-33
27. Tolbert LC, Monti JA, O'Shields H, et al. Defects in transmethylation and membrane lipids in schizophrenia. Psychopharmocol Bull 1983;19:594-9
28. Smythies JR, Alarcon RD, Bancroft AJ, et al. Role of the one-carbon cycle in neuropsychiatry. In Borchardt R, Creveling C, Ueland P, eds. Biological methylation and drug design. Clifton, NJ: Humana Press, 1986
29. Bottiglieri T, Godfrey P, Flynn T, et al. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 1990;53:1096-8
30. Spillman M, Fava M. S-adenosyl-methionine in psychiatric disorders: historical perspective and current status. CNS Drugs 1996;6:416-25
31. Ordonez LA, Wurtman RJ. Folic acid deficiency and methyl group metabolism in rat brain: effects of L-DOPA. Arch Biochem Biophys 1974;160:372-6
32. Hamon CGB, Blair JA, Barford PA. The effect of tetrahydrofolate on tetrahydrobiopterin metabolism. J Ment Defic Res 1986;30:170-83
33. Coppen A, Swade C, Jones SA, et al. Depression and tetrahydrobiopterin: the folate connection. J Affect Disord 1989;16:103-7
34. Van Praag HM. Neurotransmitters and CNS disease: depression. Lancet 1982;ii:1259-83
35. Blair J, Morar C, Hamon C, et al. Tetrahydrobiopterin metabolism in depression. Lancet 1984;ii:163
36. Curtius H, Niederwieser A, Levine R, et al. Successful treatment of depression with tetrahydrobiopterin. Lancet 1983;i:657-8
37. Fleischhacker W, Mease U, Schubert H. Re-evaluation of antidepressant effect of tetrahydrobiopterin. Lancet 1985;ii:387
38. Abou-Saleh MT, Coppen A. The biology of folate in depression: implications for nutritional hypotheses of psychoses. J Psychiatr Res 1986;20:91-101